Normal Pressure Hydrocephalus
37
7
7
11
Key Insights
Highlights
Success Rate
65% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 49/100
16.2%
6 terminated out of 37 trials
64.7%
-21.8% vs benchmark
11%
4 trials in Phase 3/4
45%
5 of 11 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 11 completed trials
Clinical Trials (37)
Evaluation of the Safety and Effectiveness of the CereVasc® eShunt® System in Normal Pressure Hydrocephalus
European Study of Prodromal iNPH
Normal Pressure Hydrocephalus and Sleep Apnea
Neurosurgical Outcome Network
White Matter Distortion and Dementia Biomarkers in Normal Pressure Hydrocephalus (NPH)
The Role of the Glymphatic System Avaluated Thourgh mr Imaging in the Diagnosis and Management of NPH
Cerebrospinal Fluid Proteome in Hydrocephalus
Predictive Value of Flow MRI in Normal Pressure Hydrocephalus Surgery
Non-invasive Diagnostics of Shunt Obstruction in Adult Hydrocephalus
Addressing Health Disparities in Normal Pressure Hydrocephalus (NPH) in Maryland
A Pilot Biomarker Study Assessing Alpha-synuclein Aggregates Across Biofluid Reservoirs in Patients With Synucleinopathies
The Usage of Telemetric Prechamber Sensor Reservoir in Management of Normal Pressure Hydrocephalus. Comparisson of Benefit for Patients with Implanted Telemetric Prechamber Sensor Reservoir.
Proteinopathies Expression in Skin of Neurodegenerative Disorders
Identifying Gait Changes From a CSF Tap Test Using a Smart Insole in iNPH
CPT-3 in Normal Pressure Hydrocephalus
Normal Pressure Hydrocephalus Biomarkers Investigation
Neurology Inpatient Clinical Education Trial
Brain Network Activation in Patients With Movement Disorders
Factors Predicting Response to Shunting in Normal Pressure Hydrocephalus
Adjustable Gravitational vs. Adjustable Differential Pressure Valves in iNPH